Adaptive mutability of colorectal cancers in response to targeted therapies

The emergence of drug resistance limits the efficacy of targeted therapies in human tumors. The prevalent view is that resistance is a fait accompli: when treatment is initiated, cancers already contain drug-resistant mutant cells. Bacteria exposed to antibiotics transiently increase their mutation...

Celý popis

Podrobná bibliografie

Vydáno v:	Science (American Association for the Advancement of Science) Ročník 366; číslo 6472; s. 1473
Hlavní autoři:	Russo, Mariangela, Crisafulli, Giovanni, Sogari, Alberto, Reilly, Nicole M, Arena, Sabrina, Lamba, Simona, Bartolini, Alice, Amodio, Vito, Magrì, Alessandro, Novara, Luca, Sarotto, Ivana, Nagel, Zachary D, Piett, Cortt G, Amatu, Alessio, Sartore-Bianchi, Andrea, Siena, Salvatore, Bertotti, Andrea, Trusolino, Livio, Corigliano, Mattia, Gherardi, Marco, Lagomarsino, Marco Cosentino, Di Nicolantonio, Federica, Bardelli, Alberto
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	United States 20.12.2019
Témata:	Adaptation, Biological - genetics Colorectal Neoplasms - drug therapy Colorectal Neoplasms - genetics DNA Mismatch Repair - genetics Down-Regulation Drug Resistance, Neoplasm - genetics ErbB Receptors - antagonists & inhibitors Humans Molecular Targeted Therapy Mutagenesis Proto-Oncogene Proteins B-raf - antagonists & inhibitors Selection, Genetic
ISSN:	1095-9203, 1095-9203
On-line přístup:	Zjistit podrobnosti o přístupu
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!